ING5 and head and neck squamous cell carcinoma: CAFs containing miR-196a within the cargo of EVs confer cisplatin resistance in head and neck squamous cell carcinoma (HNSCC) by targeting p27 and ING5, key regulators of cell cycle and apoptosis 256.